Mediwatch PLC Cancellation of Mediwatch Shares (5025Y)
January 24 2014 - 9:34AM
UK Regulatory
TIDMMDW
RNS Number : 5025Y
Mediwatch PLC
24 January 2014
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, IN OR INTO ANY RESTRICTED JURISDICTIONS OR ANY OTHER
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION
Mediwatch plc
Amendment to time of cancellation of admission of Mediwatch
Shares to trading on AIM
24 January 2014
Further to the announcement made on 22 January 2014, the
Mediwatch Directors announce that due to the change in court
availability and the Reduction Court Hearing consequently taking
place on 27 January 2014, it is expected that the cancellation of
the admission of Mediwatch Shares to trading on AIM will occur at
7.00 a.m. (London time) on 28 January 2014.
A further announcement will be made following the Reduction
Court Hearing on 27 January 2014.
Enquiries:
Mediwatch +44 (0) 1788 547
Mark Hughes, Chief Financial Officer 888
SP Angel Corporate Finance LLP
(Financial adviser, nominated adviser and
broker to Mediwatch)
David Facey
Katy Birkin
Liz Yong +44 (0) 20 3463 2260
Important Notice
This announcement is for information purposes only and does not
constitute an offer to sell or an invitation to sell, purchase,
subscribe for or issue any securities, or the solicitation of an
offer to subscribe for any securities or the solicitation of any
vote or approval in any jurisdiction pursuant to the Acquisition or
otherwise, nor shall there be any purchase, sale or exchange of
securities or such solicitation in any jurisdiction in which such
offer, solicitation, sale or exchange would be unlawful under the
laws of such jurisdiction. Any response to the Acquisition or vote
in respect of the Scheme should be made only on the basis of the
information contained in the Scheme Document.
The release, publication or distribution of this announcement in
jurisdictions other than the United Kingdom may be restricted by
law and therefore any persons who are subject to the laws of any
jurisdiction other than the United Kingdom should inform themselves
about, and observe, any applicable requirements. This announcement
has been prepared for the purpose of complying with English law and
the City Code and the information disclosed may not be the same as
that which would have been disclosed if this announcement had been
prepared in accordance with the laws of jurisdictions outside the
United Kingdom.
Copies of this announcement and any formal documentation
relating to the Acquisition are not being, and must not be,
directly or indirectly, mailed or otherwise forwarded, distributed
or sent in or into or from any Restricted Jurisdiction and persons
receiving such documents (including custodians, nominees and
trustees) must not mail or otherwise forward, distribute or send
them in or into or from any Restricted Jurisdiction.
SP Angel Corporate Finance LLP, which is authorised and
regulated by the Financial Conduct Authority in the United Kingdom,
is acting exclusively as financial adviser to Mediwatch and no one
else in connection with the matters described in this announcement,
and will not be responsible for anyone other than Mediwatch for
providing the protections afforded to clients of SP Angel Corporate
Finance LLP nor for providing advice in relation to the matters
referred to in this announcement. Neither SP Angel Corporate
Finance LLP nor any of its affiliates, partners or employees owes
or accepts any duty, liability or responsibility whatsoever
(whether direct or indirect, whether in contract, in tort, under
statute or otherwise) to any person who is not a client of SP Angel
Corporate Finance LLP in connection with this announcement, any
statement contained herein or otherwise.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEZLFLZFFXBBX
Mediwatch (LSE:MDW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mediwatch (LSE:MDW)
Historical Stock Chart
From Sep 2023 to Sep 2024